Le Lézard
Classified in: Health, Covid-19 virus
Subjects: HEALTH, LIFESTYLE

Hazel McCallion urges Canadians to get their flu shot


Mississauga, Ontario, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Revera's Chief Elder Officer, Hazel McCallion received her influenza vaccine on Tuesday, along with 50 employees at Revera's Support Office in Mississauga.

Dr. Rhonda Collins, Revera's Chief Medical Officer, was on hand to administer her flu shot, supported by representatives of MediSystem by Shoppers Drug Mart, who supply Revera's long term care homes and retirement residences with influenza vaccines.

Dr. Rhonda Collins, Revera's Chief Medical Officer, was on hand to administer her flu shot, supported by representatives of MediSystem Pharmacy and Shoppers Drug Mart Pharmacy, who supply Revera's retirement residences with influenza vaccines. This flu season, Shoppers Drug Mart Pharmacy teams across the country delivered on-site influenza vaccine to residents and staff members at 40 Revera long term care homes and retirement residences.

"I encourage everyone to take their doctor's advice and get their flu shot as soon as possible," said Hazel. "We can all help prevent serious illness and reduce the spread of the virus by being vaccinated to help keep ourselves, and our family, friends, neighbours and colleagues safe during flu season."

Revera provides influenza vaccination clinics at its retirement residences and long term care homes, as well as COVID-19 booster vaccines.

"Revera is bracing for a serious influenza season, as well as the likelihood of new outbreaks of COVID-19 variants across Canada. Influenza is expected to have a greater impact this year, as peoples' immune systems have not been widely exposed to the flu virus during the pandemic," said Dr. Rhonda Collins, Chief Medical Officer, Revera. "Revera urges everyone to be up-to-date with their COVID booster vaccines and to get their flu shot as soon as possible, as well as continuing to practice good infection prevention and control techniques such as frequent hand hygiene, masking where appropriate, and staying home if experiencing symptoms."

About Revera

Revera is a leading Canadian-owned and -headquartered, owner, investor, developer and operator in the senior living sector. Through its portfolio of partnerships, Revera owns or operates more than 500 properties across Canada, the United States and the United Kingdom serving more than 45,000 seniors. Revera offers seniors' apartments, independent living, assisted living, memory care, and long term care. With over 45,000 employees dedicated to providing exceptional care and service, Revera is helping seniors live life to the fullest. Find out more at ReveraLiving.com.

Attachments



These press releases may also interest you

at 04:45
ERS Genomics and IRBM Sign CRISPR/Cas9 License Agreement
ERS Genomics Limited (?ERS'), the CRISPR licensing Company, and IRBM, a leader in the field of drug discovery, today announced a non-exclusive CRISPR/Cas9 license agreement. The agreement grants IRBM access to ERS' CRISPR/Cas9 patent portfolio....

at 03:15
Cresilon Announces International Distribution Agreement for VETIGEL with Covetrus
Cresilon Inc. ("Cresilon"), a Brooklyn-based biotechnology company focused on haemostatic medical device technologies, today announced it has entered into a distribution agreement for its revolutionary haemostatic gel, VETIGEL®, to be sold directly...

at 02:30
New Research by Tea Advisory Panel Reveals That Three Quarters Of Brits Never Drink Tea Before A Workout Despite It Counting Towards Fluid Intake Recommendations
Ahead of International Tea Day - 21st May 2024  - and with summer inspiring more of us to get off the sofa to be active, a 2024 real-world research study1 reviewed by the tea science experts at the Tea Advisory Panel ? www.teaadvisorypanel.com -...

at 02:30
TREEFROG PRESENTS DATA FROM THEIR PARKINSON'S DISEASE CELL THERAPY PROGRAM AT THE 29TH WORLD CONGRESS ON PARKINSON'S DISEASE AND RELATED DISORDERS (IAPRD) IN LISBON
TreeFrog Therapeutics will participate for the first time at the IAPRD, to present data from their Parkinson's disease cell therapy program, which has demonstrated excellent results with full motor recovery at 16 weeks in preclinical studies.[1]...

at 02:20
Vicore Announces Positive Final Results from the Phase 2a AIR Trial Demonstrating Buloxibutid Improves Lung Function Over 36 Weeks in Patients with Idiopathic Pulmonary Fibrosis
Vicore Pharma Holding (STO:VICO)Buloxibutid improved lung function-measured by FVC-by over 200 mL from baseline at 36 weeks of treatment.The therapy was safe and well tolerated with no treatment-related serious adverse events.Biomarker analysis...

at 02:07
GC Biopharma/Novel Pharma's Sanfilippo Syndrome Treatment Obtains FDA IND Approval
GC Biopharma (006280. KS) and Novel Pharma announced that its jointly developed MPS IIIA 'GC1130A' treatment has received FDA IND approval....

More news about Health...


News published on and distributed by: